Ginkgo Bioworks Holdings (DNA) Total Liabilities (2019 - 2025)
Ginkgo Bioworks Holdings filings provide 7 years of Total Liabilities readings, the most recent being $611.1 million for Q4 2025.
- On a quarterly basis, Total Liabilities fell 7.6% to $611.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $611.1 million, a 7.6% decrease, with the full-year FY2025 number at $611.1 million, down 7.6% from a year prior.
- Total Liabilities hit $611.1 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $629.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $809.6 million in Q1 2023 to a low of $150.1 million in Q1 2021.
- Median Total Liabilities over the past 5 years was $614.6 million (2025), compared with a mean of $586.1 million.
- Biggest five-year swings in Total Liabilities: surged 203.16% in 2021 and later dropped 29.25% in 2023.
- Ginkgo Bioworks Holdings' Total Liabilities stood at $503.6 million in 2021, then soared by 59.46% to $803.0 million in 2022, then dropped by 29.25% to $568.2 million in 2023, then grew by 16.4% to $661.4 million in 2024, then fell by 7.6% to $611.1 million in 2025.
- The last three reported values for Total Liabilities were $611.1 million (Q4 2025), $629.4 million (Q3 2025), and $618.1 million (Q2 2025) per Business Quant data.